His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
Fresh Air
00:00
The Complexities of Drug Pricing
This chapter explores the intricate dynamics of drug pricing through the lens of health insurers and pharmaceutical middlemen, emphasizing the need for transparency and accountability. It reveals the struggles patients face with insurance denials and high costs while calling attention to the government's role in drug development funding vs. industry R&D claims.
Transcript
Play full episode
